ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

37,455Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 1107

$2.08M Total Retail Price of All Prescriptions

Rank: 6 out of 1107

1,057 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 1,057 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 1,057 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 29,384 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,861 1,341 S3 1 1
LEVOTHYROXINE SODIUM 1,196 942 2 3
LISINOPRIL 1,098 829 3 2
FUROSEMIDE 945 818 4 7
AMLODIPINE BESYLATE 942 798 5 6
SIMVASTATIN 883 764 6 5
OMEPRAZOLE 873 568 7 4
NAMENDA 738 736 8 42
WARFARIN SODIUM 690 591 9 15
PRAVASTATIN SODIUM 688 522 10 12
EXELON 671 671 11 103
METOPROLOL TARTRATE 618 515 12 10
METFORMIN HCL 614 432 13 8
FENOFIBRATE 594 354 14 67
GABAPENTIN 580 370 15 9
ATORVASTATIN CALCIUM 507 386 16 13
POTASSIUM CHLORIDE 475 405 17 14
CITALOPRAM HBR 443 326 18 17
MIRTAZAPINE 408 389 19 61
LANTUS SOLOSTAR 399 382 20 129
TRAMADOL HCL 390 302 21 26
METOPROLOL SUCCINATE 389 351 22 16
DONEPEZIL HCL 381 381 23 32
SERTRALINE HCL 375 275 24 20
ATENOLOL 367 288 25 19
MELOXICAM 338 221 26 25
ZOLPIDEM TARTRATE 335 193 27 22
CRESTOR 306 218 28 23
KLOR-CON M20 304 273 29 75
VITAMIN D2 301 265 30 237
POLYETHYLENE GLYCOL 3350 294 269 31 46
DIVALPROEX SODIUM 284 239 32 96
ALENDRONATE SODIUM 277 271 33 41
PANTOPRAZOLE SODIUM 275 206 34 30
HYDROCHLOROTHIAZIDE 267 201 35 11
PROMETHAZINE HCL 254 90 R 36 44
TAMSULOSIN HCL 249 216 37 30
ISOSORBIDE MONONITRATE ER 248 243 38 34
RANITIDINE HCL 241 136 39 21
TRIAMTERENE-HCTZ 240 201 40 62
FLUTICASONE PROPIONATE 237 154 41 38
GLIPIZIDE ER 231 204 42 115
GLIPIZIDE 227 170 43 64
PLAVIX 216 207 44 39
ADVAIR DISKUS 215 169 45 54
SPIRIVA 211 149 46 57
ALLOPURINOL 200 185 47 36
VENTOLIN HFA 193 66 48 97
CARVEDILOL 191 186 49 27
RISPERIDONE 169 151 50 79
CLONIDINE HCL 158 119 51 53
ESCITALOPRAM OXALATE 157 137 52 82
JANUVIA 156 107 53 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 154 107 54 24
NEXIUM 154 141 54 18
LANTUS 151 105 56 49
MUPIROCIN 150 144 57 161
SINGULAIR 146 113 58 65
TRICOR 144 91 59 95
CYCLOBENZAPRINE HCL 141 47 R 60 56
CLOPIDOGREL 140 123 61 28
ACTOS 137 96 62 132
ALPRAZOLAM 132 84 63 87
LEXAPRO 129 121 64 219
COMBIVENT 128 101 65 112
DILTIAZEM 24HR ER 128 104 65 172
DIGOXIN 127 119 67 52
PAROXETINE HCL 126 100 68 45
LOVAZA 123 92 69 101
DIOVAN 120 111 70 51
ZETIA 120 74 70 76
KLOR-CON 10 120 106 70 143
CARISOPRODOL 119 21 R 73 146
OXYBUTYNIN CHLORIDE ER 116 101 74 179
TRAZODONE HCL 116 81 74 33
FLUOXETINE HCL 113 81 76 47
IBUPROFEN 112 52 77 63
PREDNISONE 111 79 78 40
AMLODIPINE BESYLATE-BENAZEPRIL 110 97 79 77
LIPITOR 108 61 80 109
NAPROXEN 107 53 81 80
LEVETIRACETAM 107 78 81 141
TRIAMCINOLONE ACETONIDE 106 100 83 137
IPRATROPIUM-ALBUTEROL 106 105 83 154
PROAIR HFA 105 62 85 37
PREMARIN 104 34 R 86 149
AMITRIPTYLINE HCL 103 70 R 87 48
VENLAFAXINE HCL ER 103 97 87 117
GLIPIZIDE XL 100 88 89 166
LOVASTATIN 99 96 90 55
NYSTATIN 99 72 90 110
ENOXAPARIN SODIUM 98 56 92 285
AZITHROMYCIN 97 56 93 35
CYMBALTA 95 66 94 50
CELEBREX 94 79 95 85
SYMBICORT 93 68 96 124
VENLAFAXINE HCL 91 90 97 193
HYDRALAZINE HCL 90 78 98 99
CLOTRIMAZOLE-BETAMETHASONE 89 81 99 198
CIPROFLOXACIN HCL 88 69 100 59
LYRICA 87 48 101 83
GLIMEPIRIDE 86 61 102 43
TOPIRAMATE 86 26 102 160
BUMETANIDE 86 84 102 123
ARICEPT 85 85 105 289
SPIRONOLACTONE 84 77 106 72
LACTULOSE 83 83 107 89
VERAPAMIL ER 82 60 108 113
PROPRANOLOL HCL 81 57 109 134
FENTANYL 80 78 S2 110 105
CARBIDOPA-LEVODOPA 80 80 110 122
BACLOFEN 80 24 110 133
LAMOTRIGINE 79 74 113 244
BENAZEPRIL HCL 79 72 113 86
GEMFIBROZIL 78 57 115 107
NOVOLOG FLEXPEN 77 73 116 230
QUETIAPINE FUMARATE 76 63 117 94
DILTIAZEM ER 74 74 118 139
LEVOFLOXACIN 74 52 118 71
OXYCODONE-ACETAMINOPHEN 73 73 S2 120 104
PIOGLITAZONE HCL 73 46 R 120 258
ABILIFY 70 53 122 170
ACETAMINOPHEN-CODEINE 70 54 S3 122 120
SANTYL 67 65 124 255
TRIAMTERENE-HYDROCHLOROTHIAZID 66 56 125 185
BUSPIRONE HCL 64 55 126 107
EVISTA 64 64 126 135
GALANTAMINE HBR 63 63 128 277
HYDROXYZINE PAMOATE 63 36 R 128 152
NITROFURANTOIN MONO-MACRO 62 58 130 207
FAMOTIDINE 61 48 131 111
RAMIPRIL 61 35 131 84
QUINAPRIL HCL 60 60 133 145
ONGLYZA 60 51 133 205
LANSOPRAZOLE 59 48 135 102
SYNTHROID 59 53 135 70
VESICARE 58 44 137 228
METFORMIN HCL ER 58 44 137 58
NOVOFINE AUTOCOVER 57 57 139 373
CLONIDINE 57 57 139 286
THEOPHYLLINE ANHYDROUS 57 35 139 158
INSULIN SYRINGE 56 34 142 78
FLUCONAZOLE 56 22 142 150
TRILIPIX 55 37 144 153
MECLIZINE HCL 55 54 144 114
DIVALPROEX SODIUM ER 55 44 144 216
METOLAZONE 55 51 144 217
HUMALOG 54 47 148 226
CHOLESTYRAMINE 53 53 149 349
LIDODERM 53 53 149 140
ALBUTEROL SULFATE 52 25 151 144
NOVOLOG 52 34 151 127
FANAPT 52 34 151 462
DOXYCYCLINE HYCLATE 51 50 154 128
PHENYTOIN SODIUM EXTENDED 51 40 154 147
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.